|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2026-$196; 2025-$183) (amortized cost: 2026-$364,941; 2025-$357,996) | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total fixed maturities, available-for-sale, at fair value (allowance for credit losses: 2026-$196; 2025-$183) (amortized cost: 2026-$364,941; 2025-$357,996) | ||||||||||||||||||||
| Fixed maturities, held-to-maturity, at amortized cost, net of allowance for credit losses (allowance for credit losses: 2023-$0; 2022-$2) (fair value: 2023-$0; 2022-$1,455) | ||||||||||||||||||||
| Fixed maturities, held-to-maturity, at amortized cost, net of allowance for credit losses (allowance for credit losses: 2023-$0; 2022-$2) (fair value: 2023-$0; 2022-$1,455)(1) | ||||||||||||||||||||
| Fixed maturities, trading, at fair value (amortized cost: 2026-$17,658; 2025-$15,536) | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total fixed maturities, trading, at fair value (amortized cost: 2026-$17,658; 2025-$15,536) | ||||||||||||||||||||
| Assets supporting experience-rated contractholder liabilities, at fair value | ||||||||||||||||||||
| Equity securities, at fair value (cost: 2026-$11,503; 2025-$8,303) | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total equity securities, at fair value (cost: 2026-$11,503; 2025-$8,303) | ||||||||||||||||||||
| Commercial mortgage and other loans (net of $505 and $469 allowance for credit losses; includes $959 and $1,056 of loans measured at fair value under the fair value option at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total commercial mortgage and other loans (net of $505 and $469 allowance for credit losses; includes $959 and $1,056 of loans measured at fair value under the fair value option at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Other invested assets (net of $2 and $2 allowance for credit losses; includes $9,114 and $8,286 of assets measured at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total other invested assets (net of $2 and $2 allowance for credit losses; includes $9,114 and $8,286 of assets measured at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Short-term investments (net of allowance for credit losses: 2026-$10; 2025-$0) | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total accrued investment income | ||||||||||||||||||||
| Deferred policy acquisition cost | ||||||||||||||||||||
| Value of business acquired | ||||||||||||||||||||
| Market risk benefit assets | ||||||||||||||||||||
| Reinsurance recoverables and deposit receivables (net of $14 and $14 allowance for credit losses; includes $709 and $573 of embedded derivatives at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Income Tax Assets | ||||||||||||||||||||
| Other assets (net of $4 and $1 allowance for credit losses; includes $0 and $0 of assets at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total other assets (net of $4 and $1 allowance for credit losses; includes $0 and $0 of assets at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Separate account assets | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Future policy benefits | ||||||||||||||||||||
| Policyholders’ account balances | ||||||||||||||||||||
| Market risk benefit liabilities | ||||||||||||||||||||
| Policyholders’ dividends | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Cash collateral for loaned securities | ||||||||||||||||||||
| Reinsurance and funds withheld payables (includes $166 and $174 of embedded derivatives at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Income tax liabilities | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other liabilities (includes $16 and $16 allowance for credit losses and $5,759 and $6,215 of derivatives at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total other liabilities (includes $16 and $16 allowance for credit losses and $5,759 and $6,215 of derivatives at fair value at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Notes issued by consolidated variable interest entities (includes $1,807 and $767 measured at fair value under the fair value option at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total notes issued by consolidated variable interest entities (includes $1,807 and $767 measured at fair value under the fair value option at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Separate account liabilities | ||||||||||||||||||||
| Consolidated VIEs for Which the Company is the Investment Manager | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Redeemable Noncontrolling Interest, Equity, Carrying Amount | ||||||||||||||||||||
| Total mezzanine equity | ||||||||||||||||||||
| EQUITY | ||||||||||||||||||||
| Preferred Stock ($0.01 par value; $10,000,000 shares authorized; none issued) | ||||||||||||||||||||
| Common Stock ($0.01 par value; 1,500,000,000 shares authorized; 666,305,189 shares issued as of both June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Common Stock held in treasury, at cost (321,092,506 and 318,361,498 shares at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Total Prudential Financial, Inc. equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| TOTAL LIABILITIES, MEZZANINE EQUITY AND EQUITY | ||||||||||||||||||||
Loading...
